Akeso Inc
HKEX:9926
Akeso Inc?
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
31.8
77.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Akeso Inc hold over its rivals?
What risks and challenges
does Akeso Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Akeso Inc.
Provide an overview of the primary business activities
of Akeso Inc.
What unique competitive advantages
does Akeso Inc hold over its rivals?
What risks and challenges
does Akeso Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Akeso Inc.
Provide P/S
for Akeso Inc.
Provide P/E
for Akeso Inc.
Provide P/OCF
for Akeso Inc.
Provide P/FCFE
for Akeso Inc.
Provide P/B
for Akeso Inc.
Provide EV/S
for Akeso Inc.
Provide EV/GP
for Akeso Inc.
Provide EV/EBITDA
for Akeso Inc.
Provide EV/EBIT
for Akeso Inc.
Provide EV/OCF
for Akeso Inc.
Provide EV/FCFF
for Akeso Inc.
Provide EV/IC
for Akeso Inc.
Show me price targets
for Akeso Inc made by professional analysts.
What are the Revenue projections
for Akeso Inc?
How accurate were the past Revenue estimates
for Akeso Inc?
What are the Net Income projections
for Akeso Inc?
How accurate were the past Net Income estimates
for Akeso Inc?
What are the EPS projections
for Akeso Inc?
How accurate were the past EPS estimates
for Akeso Inc?
What are the EBIT projections
for Akeso Inc?
How accurate were the past EBIT estimates
for Akeso Inc?
Compare the revenue forecasts
for Akeso Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Akeso Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Akeso Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Akeso Inc compared to its peers.
Compare the P/E ratios
of Akeso Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Akeso Inc with its peers.
Analyze the financial leverage
of Akeso Inc compared to its main competitors.
Show all profitability ratios
for Akeso Inc.
Provide ROE
for Akeso Inc.
Provide ROA
for Akeso Inc.
Provide ROIC
for Akeso Inc.
Provide ROCE
for Akeso Inc.
Provide Gross Margin
for Akeso Inc.
Provide Operating Margin
for Akeso Inc.
Provide Net Margin
for Akeso Inc.
Provide FCF Margin
for Akeso Inc.
Show all solvency ratios
for Akeso Inc.
Provide D/E Ratio
for Akeso Inc.
Provide D/A Ratio
for Akeso Inc.
Provide Interest Coverage Ratio
for Akeso Inc.
Provide Altman Z-Score Ratio
for Akeso Inc.
Provide Quick Ratio
for Akeso Inc.
Provide Current Ratio
for Akeso Inc.
Provide Cash Ratio
for Akeso Inc.
What is the historical Revenue growth
over the last 5 years for Akeso Inc?
What is the historical Net Income growth
over the last 5 years for Akeso Inc?
What is the current Free Cash Flow
of Akeso Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Akeso Inc.
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
CN |
Akeso Inc
HKEX:9926
|
48.6B HKD | 26.5 | ||
FR |
Pharnext SCA
OTC:PNEXF
|
6T USD | 0 |
|
|
US |
Abbvie Inc
NYSE:ABBV
|
309.5B USD | 9.7 |
|
|
US |
Amgen Inc
NASDAQ:AMGN
|
140.9B USD | 9.6 |
|
|
US |
Gilead Sciences Inc
NASDAQ:GILD
|
112B USD | 4.9 |
|
|
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
105.6B USD | 10.7 |
|
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 410.2 |
|
AU |
CSL Ltd
ASX:CSL
|
137.8B AUD | 12.3 |
|
|
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD | 5.8 |
|
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 22.5 |
|
NL |
argenx SE
XBRU:ARGX
|
38.5B EUR | 18.6 |
|
CN |
Akeso Inc
HKEX:9926
|
Average EV/GP:
253.1
26.5
|
||
FR |
Pharnext SCA
OTC:PNEXF
|
Not Available |
|
|
US |
Abbvie Inc
NYSE:ABBV
|
9.7
|
|
|
US |
Amgen Inc
NASDAQ:AMGN
|
9.6
|
|
|
US |
Gilead Sciences Inc
NASDAQ:GILD
|
4.9
|
|
|
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
10.7
|
|
|
US |
E
|
Epizyme Inc
F:EPE
|
2 410.2
|
|
AU |
CSL Ltd
ASX:CSL
|
12.3
|
|
|
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
5.8
|
|
|
US |
S
|
Seagen Inc
F:SGT
|
22.5
|
|
NL |
argenx SE
XBRU:ARGX
|
18.6
|
|
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.